(Q44805077)

6 December 2017

title

Increased risk of adverse events when changing intravenous immunoglobulin preparations (English)

1 reference

6 December 2017

Ameratunga R

1

1 reference

6 December 2017

Sinclair J

series ordinal

2

1 reference

6 December 2017

Kolbe J

series ordinal

3

1 reference

6 December 2017

language of work or name

1 reference

1 April 2004

1 reference

Clinical and Experimental Immunology

6 December 2017

published in

1 reference

6 December 2017

volume

136

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

111-113

1 reference

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

6 December 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Clinical usage of intravenous immunoglobulins in Auckland

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Side effects of high-dose intravenous immunoglobulins

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Safety and side effects of i.v. immunoglobulin therapy.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Adverse effects of intravenous immunoglobulin

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

Side-effects of intravenous immune globulins

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

The use of intravenous immune globulin in immunodeficiency diseases

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809000

29 September 2018

Are all IGIVs the same?

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02412.X

The renal risks of high-dose intravenous immunoglobulin treatment

21 January 2018

1 reference

12 December 2020

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin

1 reference

12 December 2020

Immunosuppressive factors detected during convalescence in a patient with severe serum sickness induced by carbamazepine

1 reference

12 December 2020

IVIG adverse reactions: potential role of cytokines and vasoactive substances

1 reference

12 December 2020

10.1111/J.1365-2249.2004.02412.X

Identifiers

DOI

1 reference

6 December 2017

0 references

1 reference